Tus-Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 000590.SZ

Tus-Pharmaceutical Group Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 35.04 M

Tus-Pharmaceutical Group Co., Ltd. Current Liabilities is USD 35.04 M for the year ending December 31, 2023, a -10.91% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Tus-Pharmaceutical Group Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 39.33 M, a 33.65% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 29.43 M, a 19.30% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 24.67 M, a 11.61% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 22.10 M, a 7.79% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Shenzhen Stock Exchange: 000590.SZ

Tus-Pharmaceutical Group Co., Ltd.

CEO	Ms. Ting Tang
IPO Date	Jan. 19, 1996
Location	China
Headquarters	No. 33, Yangliu Road
Employees	1,237
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Personal Care Tobacco

Description

Tus-Pharmaceutical Group Co., Ltd. manufactures and sells traditional Chinese medicine and western medicine products. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is based in Hengyang, China.

Key trends

Past 5 years